Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

This new method improves and streamlines drug development processes

Members of the Infectious Diseases research group and the VHIR Management participated in the sessions and visited the areas where the CRESCER and FUTURO projects are developed.

The research, which is part of the CRESCER project in which Vall d'Hebron participates, has 1423 pregnant women among whom two different interventions will be tested.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

A través dels grups de recerca de Malalties Infeccioses i de Microbiologia, participem en assaigs clínics per trobar nous esquemes terapèutics per a les persones amb tuberculosi.

The team works in the African country with research projects aimed at the control of infectious diseases, chronic malnutrition and sexual and reproductive health.

Hakima Ouaarab Essadek, del Centre de Salut Internacional i Malalties Transmissibles Drassanes-Vall d'Hebron, assessorarà en el Departament de Salut en l’abordatge de les desigualtats de gènere.

The sessions have brought together experts who have presented the advances and knowledge generated in the area of HIV infection.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Els ajuts impulsaran estudis en els camps del VIH, les hepatitis virals i la COVID-19.

The research, published in The Lancet, studied patients in Barcelona and Madrid, and shows that direct contact is the main route of transmission for the disease.

HIV infected cells expressing the CD32 molecule are more resistant to the action of the natural killer cells of the immune system, which are key in the fight against viral infections.

Entre els projectes més rellevants en Covid-19 destaca la participació del VHIR en assaigs clínics per provar l’eficàcia i seguretat de vacunes com ara Janssen, Pfizer-BioNTech en el col·lectiu d’embarassades, i Hipra.

Researchers have detected for the first time that people with type 2 diabetes who have insulin resistance in the myocardium have structural alterations of the heart and more calcifications in the coronary arteries that increase their risk of cardiovascular disease.

The system can rapidly identify viral targets and the expression of viral entry factors, as well as detect inhibitors of viral entry into cells and anti-inflammatory compounds.

The project COCREA SASI. Co creation for the promotion of affective-sexual health from an intercultural perspective has won the award for Best Research Paper.

És el primer cop que s’analitzen totes les cèl·lules que conformen el reservori del VIH a la sang a la vegada, descrivint de quina manera i en quins subtipus de cèl·lules en concret s’ubica aquest reservori en persones que reben tractament antiretroviral

 

  

The nurse received this recognition thanks to HEPARJOC-ACTUA, an educational tool to improve the diagnosis of Hepatitis B.

This research has shown the efficacy of dual therapy for HIV treatment, with dolutegravir and lamivudine, compared with the standard treatment with three drugs.

Vall d’Hebron University Hospital diagnosed the first case of HIV in Spain in October 1981. This was a 35 year-old man who was admitted to hospital with Kaposi’s sarcoma and other opportunistic infections.